Study title:
Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F.
Combined foscarnet - ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (hsct). Bone Marrow Transplantation 1996;18SUPPL:110-4 1996.Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F.
Combined foscarnet - ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (hsct). Bone Marrow Transplantation 1996;18SUPPL:110-4 1996.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Virus Diseases [C02]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Foscarnet |
ATC code: |
Document link:
Bacigalupo A et al 1996 supplement.pdf
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
Y
|